Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Interventional Oncology Devices Market Expected To Become By 2029 Compared With Its 2025 Level?
The market for interventional oncology devices has demonstrated consistent upward momentum through recent years, projected to expand from a value of $2.39 billion in 2024 to $2.5 billion the following year, reflecting a compound annual growth rate (CAGR) of 4.4%. This upward trajectory observed during the historical period is linked to several key factors, including a burgeoning elderly demographic, a rise in cancer incidence across populations, greater investment in pharmaceutical research and development, escalating overall healthcare spending, and an augmentation in the availability of medical care establishments.
Anticipation surrounds the interventional oncology devices sector, projecting a robust expansion in the upcoming years, with market valuation projected to reach an impressive $3.28 billion by 2029, underpinned by a compound annual growth rate (CAGR) of 7.0%; this upward trajectory is fueled by several key factors, including the expanding demographic of elderly individuals, a growing inclination toward minimally invasive surgical techniques, escalated investment in research and development initiatives, a general upward trend in healthcare spending, untapped opportunities within developing nations, and the rising incidence rates associated with cancer and various chronic illnesses; meanwhile, dominant trends shaping this market landscape involve a concentrated effort toward engineering sophisticated, image-guided oncology apparatus, the integration of artificial intelligence for pioneering device creation, the introduction of novel embolic agents designed to enhance oncological interventions, an increased emphasis on leveraging robotic technologies, and strategic alliances formed with other enterprises and academic bodies to fast-track both product enhancement and groundbreaking discoveries.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp
Which Major Market Drivers Are Shaping The Future Of The Interventional Oncology Devices Market?
A central strategy for key players within the interventional oncology device sector is concentrating efforts on advancements like tissue volume measurement to elevate both the precision of diagnostic assessments and the overall success rate of oncological interventions. Tissue volume is defined by the quantity of biological material secured throughout the biopsy process; securing greater tissue amounts generally leads to more thorough sample data, thereby boosting diagnostic reliability and refining the suitability of treatment strategies. Illustratively, in June of 2023, Argon Medical, a medical device firm situated in the United States, introduced its SuperCore Advantage semi-automatic biopsy system, a device capable of gathering samples that surpass those of primary rivals by as much as 35 percent, consequently minimizing the necessity for repeated puncture attempts during the biopsy, a capability vital for ensuring sufficient tissue acquisition essential for a precise diagnosis.
How Is The Interventional Oncology Devices Market Segmented?
The interventional oncology devicesmarket covered in this report is segmented –
1) By Product: Embolization Devices, Ablation Devices, Support Devices
2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types
Subsegments:
1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents
2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices
3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems
Which Key Trends Are Expected To Influence The Interventional Oncology Devices Market In The Coming Years?
A key trend among leading corporations involves the incorporation of robotics into interventional oncology instruments, aiming to achieve superior operational effectiveness. This robotic framework successfully merges pre-procedure imaging guidance and navigation capabilities with the precise placement of various tools into the targeted anatomical region, thereby enhancing both accuracy and throughput. A concrete illustration of this progress is the U.S. Food and Drug Administration’s endorsement in March 2022 of Quantum Surgical’s Epione interventional oncology robotics system.
Who Are The Key Multinational Companies Dominating The Interventional Oncology Devices Market?
Major companies operating in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, Dr.Reddys, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic plc, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc, Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International
Download The Full Report For Exclusive Market Findings:
Which Global Regions Are Influencing The Competitive Landscape Of The Interventional Oncology Devices Market?
North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Interventional Oncology Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp
Browse Through More Reports Similar to the Global Interventional Oncology Devices Market 2025, By The Business Research Company
Oncology Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report
3D Medical Imaging Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/3d-medical-imaging-devices-global-market-report
Cancer Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model